Welcome to our dedicated page for Lite Strategy SEC filings (Ticker: LITS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lite Strategy, Inc. (LITS) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. These documents explain how Lite Strategy reports its transition from MEI Pharma into a business that combines a Litecoin-focused digital asset treasury strategy with the management and potential monetization of legacy pharmaceutical assets.
Through Forms 8-K and related amendments, Lite Strategy describes material events such as its corporate name and ticker change, capital raising transactions, and governance changes. Filings detail the authorization and terms of private placement offerings, including pre-funded warrants, and subsequent exercises that impact the company’s capital structure. They also document the authorization of a share repurchase program, outlining how and under what conditions the company may repurchase its common stock.
Regulatory filings further cover board and executive matters, including director resignations, committee roles, and the appointment of the company’s Chief Financial Officer and Secretary as permanent Chief Executive Officer and board member. Associated equity compensation grants, such as stock options under the company’s omnibus equity plan and corrections to previously reported option awards, are described in detail, including vesting schedules and exercise prices.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand items like executive compensation arrangements, capital markets transactions, and treasury-related decisions. Real-time updates from EDGAR ensure that new 8-Ks, registration-related filings, and other reports appear promptly, while AI-generated insights make it easier to interpret complex legal and financial language without reading every page.
Lite Strategy, Inc. (filing excerpts) discloses equity plan details, leadership changes, executive pay and severance terms, option activity, license and contingent payment obligations, and committee responsibilities. The company has omnibus and inducement equity plans authorizing 1,850,739 and 217,000 shares respectively, with specific option pools and weighted-average exercise prices reported. Leadership changes included resignations of the CEO and CMO effective August 1, 2024, with separation agreements providing severance, COBRA and accelerated vesting; one former CEO received $614,000 severance. Justin J. File became Acting CEO (in addition to CFO) and received total annual compensation of $912,667 and a $275,000 annual incentive plus a $96,000 success fee tied to cash retention. The filing notes cashless exercises and warrant conversions totaling millions of shares issued and lists committee charters and oversight duties for audit, compensation and nominating committees.
Lite Strategy, Inc. reported that an investor exercised a portion of previously issued pre-funded warrants. These warrants were originally issued on July 22, 2025 in a private PIPE offering at an offering price of $3.4199 per pre-funded warrant for up to 6,022,869 shares of common stock.
On September 10, 2025, the investor exercised 1,595,000 pre-funded warrants in a cashless transaction, receiving 1,594,944 shares of Lite Strategy common stock. The warrants and the shares issued upon exercise were issued in transactions relying on private offering exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.